 Co-Diagnostics Inc NASDAQ:CODX has announced the appointment of Mark Poritz as the companys new chief scientific officer CSO. Poritz is a Harvard University-educated molecular biologist with more than 30 years of experience in the application of polymerase chain reaction PCR and related methods to gene cloning, drug discovery, infectious disease diagnostics and aptamer selection. 